Two recent studies from researchers at Washington University School of Medicine in St. Louis have identified a promising way ...
The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback